GORMAN KEVIN CHARLES sold NBIX
February 13, 2026 · Form 4 insider transaction
GORMAN KEVIN CHARLES sold 34,380 shares of Neurocrine Biosciences, Inc. at $124.12 per share, a transaction worth $4.27M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
34,380
Price
$124.12
Total value
$4.27M
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after551,293
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of restricted stock units ("RSUs") or performance restricted stock units ("PRSUs"), as applicable. No shares were sold.; 551,293 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.